Results 151 to 160 of about 12,976 (174)
Some of the next articles are maybe not open access.
Cimetidine for Kaposi's sarcoma
Clinical and Experimental Dermatology, 1985[No abstract available]
CALVIERI, Stefano, Andrea Fattorossi
openaire +2 more sources
International Journal of Dermatology, 2007
AbstractBackground The prevalence of Kaposi's sarcoma (KS) in parts of Africa has been on the increase as a result of the human immunodeficiency virus (HIV) infection pandemic. However, there is a paucity of information for Nigeria.Objective To describe the clinical and epidemiological characteristics of cutaneous KS in patients with HIV‐infection in
Abel N, Onunu +5 more
openaire +2 more sources
AbstractBackground The prevalence of Kaposi's sarcoma (KS) in parts of Africa has been on the increase as a result of the human immunodeficiency virus (HIV) infection pandemic. However, there is a paucity of information for Nigeria.Objective To describe the clinical and epidemiological characteristics of cutaneous KS in patients with HIV‐infection in
Abel N, Onunu +5 more
openaire +2 more sources
Pathogenesis of Kaposi's sarcoma
Hematology/Oncology Clinics of North America, 2003Kaposi's sarcoma (KS) is a disease characterized by proliferative vascular lesions, which almost invariably contain the KS-associated herpesvirus (KSHV), also called human herpesvirus 8. KSHV is a lymphotrophic and angiotrophic herpesvirus, whose genome encodes several proteins involved in proliferation, antiapoptotic functions, and inflammation.
Darya, Bubman, Ethel, Cesarman
openaire +2 more sources
Current Opinion in Oncology, 2003
Knowledge of the pathophysiology of Kaposi sarcoma continues to expand and influence our therapeutic approaches. This review summarizes developments within the last 18 to 24 months.Pieces of the puzzle as they relate to viral factors-both human herpes virus 8 (HHV-8) and human immunodeficiency virus (HIV)-endothelial cells, host immune factors, and ...
openaire +2 more sources
Knowledge of the pathophysiology of Kaposi sarcoma continues to expand and influence our therapeutic approaches. This review summarizes developments within the last 18 to 24 months.Pieces of the puzzle as they relate to viral factors-both human herpes virus 8 (HHV-8) and human immunodeficiency virus (HIV)-endothelial cells, host immune factors, and ...
openaire +2 more sources
Annals of Internal Medicine, 1985
Excerpt To the editor: The number of patients with endemic (classic) Kaposi's sarcoma seen in tropical Africa greatly exceeds that seen in all other continents.
openaire +2 more sources
Excerpt To the editor: The number of patients with endemic (classic) Kaposi's sarcoma seen in tropical Africa greatly exceeds that seen in all other continents.
openaire +2 more sources
Kaposi sarcoma in transplantation
Transplantation Reviews, 2008Kaposi sarcoma (KS) is a multicentric neoplasm of lymphatic endothelium derived cells infected with Kaposi's human herpesvirus 8 (HHV8). Post-transplant KS can lead to multifocal, progressive (florid) lesions with frequent primary involvement of the oral mucosa and dissemination to the viscera.
Céleste, Lebbé +2 more
openaire +2 more sources
Kaposi sarcoma of the oesophagus
The British Journal of Radiology, 1980Kaposi sarcoma is pleomorphic and ubiquitous. Skeletal changes used to be the only recognized radiological manifestations of the disease and the literature contains very little information of the extra-osseous radiological findings. It is now realized that whilst radiological abnormalities of the gastrointestinal tract are rare, histological lesions ...
openaire +2 more sources
Kaposi’s Sarcoma: A Reevaluation
1995Kaposi's sarcoma (KS) is a multicentric neoplasia of microvascular origin arising during development of immunodeficiency in human immunodeficiency virus (HIV)-infected individuals. More than 130 patients with HIV-associated KS (98% male homosexuals; median age, 35 years) have been diagnosed at the Department of Dermatology, University Medical Center ...
C E, Orfanos +3 more
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1963
MULTIPLE HEMORRHAGIC SARCOMA of Kaposi is a rare disease of unknown etiology. 1 In this disease there appears to be three more or less distinct stages: inflammatory, granulomatous, and neoplastic. It usually starts as ill-defined, doughy, infiltrated plaques or collections of several firm, bean-to-pea size, reddish or purplish nodules, often with ...
openaire +2 more sources
MULTIPLE HEMORRHAGIC SARCOMA of Kaposi is a rare disease of unknown etiology. 1 In this disease there appears to be three more or less distinct stages: inflammatory, granulomatous, and neoplastic. It usually starts as ill-defined, doughy, infiltrated plaques or collections of several firm, bean-to-pea size, reddish or purplish nodules, often with ...
openaire +2 more sources
Journal of Surgical Oncology, 2004
AbstractWhile there have been many important advances in the study of Kaposi's sarcoma (KS), it remains both a challenge and an enigma in many ways. Kaposi's original description of “multiple idiopathic hemorrhagic sarcoma[s]” in patients who died within 2–3 years resembles KS in AIDS more than classic KS in elderly men of Italian, Jewish, or ...
openaire +2 more sources
AbstractWhile there have been many important advances in the study of Kaposi's sarcoma (KS), it remains both a challenge and an enigma in many ways. Kaposi's original description of “multiple idiopathic hemorrhagic sarcoma[s]” in patients who died within 2–3 years resembles KS in AIDS more than classic KS in elderly men of Italian, Jewish, or ...
openaire +2 more sources